← SynDRA
EMRICASAN
SynDRA canonical compound SYN0005992 — structure-anchored drug synonym record
| Clinical phase | Phase 2 |
|---|
| Primary target(s) | CASP1 | CASP3 | CASP7 | CASP8 | CASP9 |
|---|
| Mechanism of action | caspase inhibitor |
|---|
All known targets
- CASP1
- CASP3
- CASP7
- CASP8
- CASP9
- CASP10
- CASP12
- CASP14
- CASP2
- CASP4
- CASP5
- CASP6
Mechanisms of action (all sources)
- CASP4 INHIBITOR
- Caspase inhibitor
- CASP9 INHIBITOR
- CASP3 INHIBITOR
- CASP5 INHIBITOR
- CASP6 INHIBITOR
- CASP7 INHIBITOR
- CASP8 INHIBITOR
- CASP1 INHIBITOR
- CASP2 INHIBITOR
- CASP10 INHIBITOR
- CASP14 INHIBITOR
Cross-references
Synonyms
- IDN-6556
- PF-03491390
- VAY-785
- VAY785
- IDN 6556
- PF 03491390
- UNII-P0GMS9N47Q
- (S)-3-((S)-2-(2-(2-TERT-BUTYLPHENYLAMINO)-2-OXOACETAMIDO)PROPANAMIDO)-4-OXO-5-(2,3,5,6-TETRAFLUOROPHENOXY)PENTANOIC ACID
- P0GMS9N47Q
- (S)-3-((S)-2-(2-((2-(tert-Butyl)phenyl)amino)-2-oxoacetamido)propanamido)-4-oxo-5-(2,3,5,6-tetrafluorophenoxy)pentanoic acid
- Emricasan [USAN:INN]
- Emricasan (USAN/INN)
- SCHEMBL3288801
- GTPL6508
- CHEMBL197672
- DTXSID10180160
- MolPort-027-835-564
- C26H27F4N3O7
- BCP07463
- EX-A1659
- s7775
- 2073AB
- ZINC14191207
- emricasanum
- RefChem:590768
- PF03491390
- DTXCID20102651
- IDN6556
- MFCD11840420
- Emricasan [USAN]
- Emricasan?
- EMRICASAN [INN]
- EMRICASAN [WHO-DD]
- orb1300430
- SCHEMBL29714117
- BDBM50461533
- AKOS016009462
- CCG-270089
- CS-0599
Look up EMRICASAN in the interactive SynDRA portal →